CUSIP: 29363K105
Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
7,709,342
-
Share change
-
+7,679,342
-
Total reported value
-
$168,852,338
-
Price per share
-
$21.90
-
Number of holders
-
48
-
Value change
-
+$168,195,338
-
Number of buys
-
47
Quarterly Holders Quick Answers
What is CUSIP 29363K105?
CUSIP 29363K105 identifies ENTL - ENTELLUS MED INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 29363K105:
Institutional Holders of ENTELLUS MED INC - COM (ENTL) as of Q1 2015
As of 31 Mar 2015,
ENTELLUS MED INC - COM (ENTL) was held by
48 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,709,342 shares.
The largest 10 holders included
Essex Woodlands Health Ventures, Inc., FMR LLC, RS INVESTMENT MANAGEMENT CO LLC, LORD, ABBETT & CO. LLC, WELLS FARGO & COMPANY/MN, KINGDON CAPITAL MANAGEMENT, L.L.C., PRICE T ROWE ASSOCIATES INC /MD/, NEXT CENTURY GROWTH INVESTORS LLC, Ghost Tree Capital, LLC, and BlackRock Fund Advisors.
This page lists
48
institutional shareholders reporting positions in this security
for the Q1 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.